RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. More Details
Acceptable track record with limited growth.
Share Price & News
How has RadNet's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: RDNT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: RDNT's weekly volatility (7%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: RDNT exceeded the US Healthcare industry which returned 31.6% over the past year.
Return vs Market: RDNT exceeded the US Market which returned 30.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is RadNet's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StReturns At RadNet (NASDAQ:RDNT) Appear To Be Weighed Down
1 month ago | Simply Wall StA Look At The Fair Value Of RadNet, Inc. (NASDAQ:RDNT)
1 month ago | Simply Wall StDo Insiders Own Lots Of Shares In RadNet, Inc. (NASDAQ:RDNT)?
Is RadNet undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: RDNT ($28.2) is trading below our estimate of fair value ($31.46)
Significantly Below Fair Value: RDNT is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: RDNT is poor value based on its PE Ratio (61.3x) compared to the US Healthcare industry average (22.1x).
PE vs Market: RDNT is poor value based on its PE Ratio (61.3x) compared to the US market (17.1x).
Price to Earnings Growth Ratio
PEG Ratio: RDNT is poor value based on its PEG Ratio (3.7x)
Price to Book Ratio
PB vs Industry: RDNT is overvalued based on its PB Ratio (7.6x) compared to the US Healthcare industry average (3.3x).
How is RadNet forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RDNT's forecast earnings growth (16.7% per year) is above the savings rate (2%).
Earnings vs Market: RDNT's earnings (16.7% per year) are forecast to grow faster than the US market (14.8% per year).
High Growth Earnings: RDNT's earnings are forecast to grow, but not significantly.
Revenue vs Market: RDNT's revenue (5.8% per year) is forecast to grow slower than the US market (9.5% per year).
High Growth Revenue: RDNT's revenue (5.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RDNT's Return on Equity is forecast to be high in 3 years time
How has RadNet performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: RDNT has high quality earnings.
Growing Profit Margin: RDNT became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: RDNT's earnings have grown by 0.4% per year over the past 5 years.
Accelerating Growth: RDNT has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: RDNT has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (32.2%).
Return on Equity
High ROE: RDNT's Return on Equity (14.4%) is considered low.
How is RadNet's financial position?
Financial Position Analysis
Short Term Liabilities: RDNT's short term assets ($334.9M) do not cover its short term liabilities ($381.3M).
Long Term Liabilities: RDNT's short term assets ($334.9M) do not cover its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: RDNT's debt to equity ratio (253.9%) is considered high.
Reducing Debt: RDNT's debt to equity ratio has reduced from 1688.4% to 253.9% over the past 5 years.
Debt Coverage: RDNT's debt is well covered by operating cash flow (21.2%).
Interest Coverage: RDNT's interest payments on its debt are not well covered by EBIT (2.7x coverage).
What is RadNet current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate RDNT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate RDNT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if RDNT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if RDNT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of RDNT's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Howard Berger (75 yo)
Dr. Howard G. Berger, M.D., serves as the President and Chief Financial Officer of Image Medical Corporation. Dr. Berger has been the Chief Executive Officer and President at RadNet, Inc. and its predecess...
CEO Compensation Analysis
Compensation vs Market: Howard's total compensation ($USD2.84M) is about average for companies of similar size in the US market ($USD3.66M).
Compensation vs Earnings: Howard's compensation has been consistent with company performance over the past year.
Experienced Management: RDNT's management team is considered experienced (4.6 years average tenure).
Experienced Board: RDNT's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: RDNT insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3%.
RadNet, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: RadNet, Inc.
- Ticker: RDNT
- Exchange: NasdaqGM
- Founded: 1985
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$1.499b
- Shares outstanding: 53.14m
- Website: https://www.radnet.com
Number of Employees
- RadNet, Inc.
- 1508, 1510 and 1516 Cotner Avenue
- Los Angeles
- United States
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission t...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/16 05:04|
|End of Day Share Price||2021/09/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.